Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs

Journal of Controlled Release

Volumn 89, Issue 2, 2003, Pages 311-320

  Sintov, Amnon C ^a   Krymberk, Igor ^a   Daniel, Dorit ^b   Hannan, Talli ^b   Sohn, Ze'ev ^b   Levin, Galit ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TransPharma Ltd   (Israel)

Author keywords

Diclofenac; Granisetron; Radiofrequency ablation; Radiofrequency microchannels; Skin permeation; Transdermal delivery

Indexed keywords

DRUG DOSAGE; HYDROPHILICITY; MICROELECTRODES; MICROELECTRONICS;

SKIN MICROCHANNELING;

SKIN;

DICLOFENAC; GRANISETRON;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DEVICE; DRUG DELIVERY SYSTEM; EPIDERMIS; HYDROGEL; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY; RAT; SKIN PENETRATION; SKIN PERMEABILITY; STEADY STATE; STRATUM CORNEUM;

EID: 0037472111     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00123-8     Document Type: Article

References (26)

1. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Hadgraft J., Guy R.H. Transdermal Drug Delivery, Developmental Issues and Research Initiatives. 1989;197-246 Marcel Dekker, Inc. New York and Basel.
2. Smith E.W., Maibach H.I. Percutaneous Penetration Enhancers. 1995;CRC Press, Boca Raton, FL.
3. Henry S., McAllister D.V., Allen M.G., Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug. J. Pharm. Sci. 87:1998;922-925.
4. McAllister D.V., Allen M.G., Prausnitz M.R. Microfabricated microneedles for gene and drug delivery. Ann. Rev. Biomed. Eng. 2:2000;298-313.
5. Singh P., Liu P., Dinh S.M. Facilitated transdermal delivery by iontophoresis. Bronaugh R.L., Maibach H.I. Percutaneous Absorption, Drugs-Cosmetics-Mechanisms-Methodology. 3rd Edition:1999;633-657 Marcel Dekker, Inc. New York and Basel.
6. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Del. Rev. 46:2001;281-305.
7. Bath B.D., White H.S., Scott E.R. Visualization and analysis of electroosmotic flow in hairless mouse skin. Pharm. Res. 17:2000;471-475.
8. Prausnitz M.R., Bose V.G., Langer R., Weaver J. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
9. Vanbever R., Lecouturier N., Preat V. Transdermal delivery of metoprolol by electroporation. Pharm. Res. 11:1994;1657-1662.
10. Riviere J.E., Monteiro-Riviere N.A., Rogers R.A., Bommannan D., Tamada J.A., Potts R.O. Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology. J. Controlled Release. 36:1995;229-233.
11. Vanbever R., Le Boulenge E., Preat V. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors. Pharm. Res. 13:1996;559-565.
12. Prausnitz M.R. A practical assessment of transdermal drug delivery by skin electroporation. Adv. Drug Del. Rev. 35:1999;61-76.
13. Hu Q., Liang W., Bao J., Ping Q. Enhanced transdermal delivery of tetracaine by electroporation. Int. J. Pharm. 202:2000;121-124.
14. Kost J., Mitragotri S., Langer R. Phonophoresis. Bronaugh R.L., Maibach H.I. Percutaneous Absorption, Drugs-Cosmetics-Mechanisms-Methodology. 3rd Edition:1999;615-631 Marcel Dekker, Inc. New York and Basel.
15. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res. 17:2000;1354-1359.
16. Bommannan D., Tamada J., Leung L., Potts R.O. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. 11:1994;1809-1814.
17. Chang S-L., Hofmann G.A., Zhang L., Deftos L.J., Banga A.K. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Controlled Release. 66:2000;127-133.
18. Izzo F., Barnett C.C., Curley S.A. Radiofrequency ablation of primary and metastatic malignant liver tumors. Adv. Surg. 35:2001;225-250.
19. Nahum Goldberg S. Radiofrequency tumor ablation: principles and techniques. Eur. J. Ultrasound. 13:2001;129-147.
20. Solbiati L., Ierace T., Tonolini M., Osti V., Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur. J. Ultrasound. 13:2001;149-158.
21. McGovern F.J., Wood B.J., Nahum Goldberg S., Mueller P.R. Radiofrequency ablation of renal cell carcinoma via image guided needle electrodes. J. Urol. 161:1999;599-600.
22. Z. Avrahami, Transdermal Drug Delivery and Analyte Extraction, US Patent No. 6,148,232, (2000).
23. Kudoh S., Sato T., Okada H., Kumakura H., Nakamura H. Simultaneous determination of granisetron and 7-hydroxygranisetron in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B. 660:1994;205-210.
24. Weaver J.C., Chizmadzhev Y.A. Theory of electroporation: a review. Bioelectrochem. Bioenerg. 41:1996;135-160.
25. Burnette R.R., Ongpipattanakul B. Characterization of the preselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76:1987;765-773.
26. Panchagnula R., Stemmer K., Ritschel W.A. Animal models for transdermal drug delivery. Meth. Find. Exp. Clin. Pharmacol. 19:1997;335-341.